Form 8-K - Current report:
SEC Accession No. 0001193125-25-137422
Filing Date
2025-06-09
Accepted
2025-06-09 07:04:25
Documents
15
Period of Report
2025-06-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d50153d8k.htm   iXBRL 8-K 66253
5 GRAPHIC g50153dsp003.jpg GRAPHIC 62793
6 GRAPHIC g50153dsp004.jpg GRAPHIC 84179
7 GRAPHIC g50153dsp005.jpg GRAPHIC 58528
  Complete submission text file 0001193125-25-137422.txt   724734

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtsr-20250609.xsd EX-101.SCH 2876
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtsr-20250609_lab.xml EX-101.LAB 18736
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtsr-20250609_pre.xml EX-101.PRE 11724
17 EXTRACTED XBRL INSTANCE DOCUMENT d50153d8k_htm.xml XML 3772
Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Filer) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42489 | Film No.: 251032805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)